Autopsy report · NCT02566889

An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease

“Study was terminated due to the inability to enroll a sufficient number of the required subject population”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 3 years 3 months before it stopped.
• 53 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Janssen Scientific Affairs, LLC

Sponsor type

Industry

Conditions

Inflammatory Bowel Diseases

Interventions

Infliximab

Participants

53

Sites

36

Countries

Canada, United States

Trials that died the same way

• Moderate to Persistent Asthma in the Obese Subject
  “Unable to enroll enough study subjects. Study has been terminated” (85% match in meaning)
• Placebo Controlled Trial of Bosentan in Scleroderma Patients
  “Study was terminated due to inadequate enrolment” (83% match in meaning)
• Virtue® Male Sling Fixation Study
  “The study has been terminated due to lack of subject enrollment.” (83% match in meaning)
• A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
  “Study was terminated due to poor enrollment” (82% match in meaning)
• Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
  “The study was terminated due to low enrollment” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.